Banned cycling drug does not affect performance, says new study
The banned cycling drug known as EPO does not affect cycling performance, according to a new Leiden study, published in The Lancet on Thursday.
Scientists from the Centre for Human Drug Research said that ‘scientific evidence behind doping is weak’ despite potential performance-enhancing drugs being forbidden.
But its test of 18-50 year old men, with various controls, showed no differences in cycling performance between those who had taken recombinant human erythropoietin (rHuEPO) and those who had not.
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.
Make a donation